The Saving Dose

John Hsu, Kendra Allen, William Pedranti
  • 5.0 (2)
  • Medicine

The podcast for those building the future of healthcare. A clinician, a healthcare attorney, and a behavioral health executive on what's actually working in addiction, adherence, and the capital reshaping both.75% of patients do not take medications as prescribed. 125,000 Americans die from it every year. $528 billion in preventable costs trace directly to a gap the healthcare system has known about for decades and never closed: what happens after the prescription is written. The Saving Dose is a podcast about that gap, the space between the clinic visit and the outcome, between the evidence-based treatment and the patient who never receives it, between the innovation that works and the reimbursement system that decides whether anyone can afford to deliver it. Hosted by Kendra Allen, Dr. John Hsu, and William Pedranti, the show brings together a behavioral health revenue strategist, an addiction medicine physician, and a biotech entrepreneur to go inside the clinical, operational, and commercial realities of addiction recovery, medication adherence, opioid use disorder (OUD), and behavioral health. Three different vantage points on the same broken system. Honest about what fails, specific about why, and direct about what a real fix requires. Topics include: MOUD and MAT clinic operations, medication-assisted treatment adherence, behavioral health reimbursement, opioid use disorder treatment, payer contracting, DEA compliance, FFS-to-value-based care transitions, and the patient adherence gap in controlled substance prescribing. The Saving Dose is for investors evaluating the addiction recovery and behavioral health infrastructure market. For clinic operators and executives running opioid treatment programs, MOUD practices, and behavioral health facilities. For clinicians in addiction medicine and pain management. For payers and administrators navigating the cost and risk of behavioral health coverage. New episodes every two weeks. Available on Spotify, Apple Podcasts, YouTube, and wherever you listen.

Episodes

  1. 6h ago

    Investigative Reporter on How Opioid Settlement Funds Are Spent | The Saving Dose Ep. 07 ft. Ed Mahon

    In the seventh episode of The Saving Dose, Dr. John Hsu and William Pedranti are joined by Ed Mahon, an investigative journalist at Spotlight PA who has spent years covering how opioid settlement funds are being allocated across Pennsylvania and who actually has a say in those decisions. The opioid epidemic has generated one of the largest legal settlements in American history. Billions of dollars have been distributed to states and counties with the stated purpose of funding addiction treatment, recovery services, and prevention programs. What is actually happening with that money, and whether the communities most affected by the crisis have a seat at the table when spending decisions are made, is a question most media coverage has not answered. That is what Ed covers. This episode goes inside the accountability gap at the center of the settlement distribution process, why the voices of people directly affected by addiction are still being left out of policy decisions, and what investigative journalism is doing to close that gap in Pennsylvania. In this episode: What the opioid settlement funds are, where they came from, and why the distribution of billions of dollars to states and counties has not automatically translated into better treatment access for the people who need it most. Who is making the decisions about how settlement money gets spent, why those decision-making bodies often do not include people with lived experience of addiction or recovery, and what that absence costs in terms of policy effectiveness. What Spotlight PA's Voices of the Epidemic series uncovered about the gap between how officials describe the settlement spending and what is actually happening on the ground in affected communities. Why Pennsylvania is a useful lens for the national picture: what the state's experience with the opioid crisis, from rural counties to Philadelphia, reveals about the structural challenges that no amount of settlement money fixes on its own. The intersection of chronic pain and addiction: why 25% of Americans living with chronic pain and nearly 50 million Americans with some form of substance use disorder are not entirely separate populations, and what treating both in the same patient requires. John's multimodal pain treatment approach: ultrasound-guided pain blocks, anti-seizure medications, acupuncture, TENS units, and physical therapy — a framework he has been using since 1999 when a colleague accused him of practicing Chinese medicine on American patients. Why 75% of patients do not take their medications correctly, why complete medication transparency is essential to individualizing care, and what happens to treatment outcomes when that transparency is missing. What people who want to make a difference on the opioid crisis can do, and where to follow Ed's ongoing investigative coverage. About the Hosts John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch. Connect with John: https://www.linkedin.com/in/john-hsu-md-300a8b2a/ William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit. Connect with William: https://www.linkedin.com/in/williampedranti/ About the Guest Ed Mahon is an investigative journalist at Spotlight PA covering opioid settlement accountability and addiction policy in Pennsylvania. His work focuses on how settlement funds are allocated, who has a voice in those spending decisions, and elevating the perspectives of people directly affected by the opioid crisis. Follow his work at spotlightpa.org. Website: thesavingdose.com This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions. #OpioidSettlement #OpioidCrisis #AddictionRecovery #BehavioralHealth #PublicHealth #TheSavingDose #HealthcarePodcast #OpioidUseDisorder #InvestigativeJournalism #DrugPolicy #AddictionMedicine #ChronicPain #PainManagement #SubstanceUseDisorder #Pennsylvania #OpioidFunding #RecoveryPodcast #MOUD

  2. Jul 21

    Why Chronic Pain Is Under-treated in the USA | The Saving Dose Ep. 06 Ft. Kevin James

    In the sixth episode of The Saving Dose, Dr. John Hsu and William Pedranti are joined by Kevin James, a chronic pain patient, advocate, and member of Chronic Pain Australia, speaking from Brisbane, Queensland.  Kevin has lived with chronic pain for years. He has navigated the Australian healthcare system, fought for access to treatment, and watched the fear campaign around opioid prescribing export itself from the United States to the rest of the world. He is not speaking as a physician or a policy expert. He is speaking as someone who has sat on the other side of the desk and has been told his pain was not real, or was manageable without medication, or was something psychological exercises could fix. This episode covers what chronic pain actually looks like from the inside, why global overcorrection on opioid prescribing is leaving legitimate pain patients without treatment, what holistic pain management actually means when it is done correctly, and why Kevin's message to every prescriber, policymaker, and clinic operator comes down to one sentence: holistic care is the biscuit. In this episode: What it is like to be a chronic pain patient navigating a healthcare system that has been reshaped by fear rather than evidence, and why access to adequate pain treatment has become harder even for patients with documented, diagnosed conditions. Why the opioid fear campaign that originated in the United States has spread globally, what it is doing to pain management practices in Australia, and why Kevin believes America's prescribing overcorrection is being imported by countries that did not need it. The difference between opioid dependency and opioid use disorder from a patient's perspective, and why conflating the two has caused legitimate pain patients to be treated as addicts when they are not. What holistic pain management actually requires: not just psychological exercises and pain reprocessing therapy, but medication, individual treatment, and a care plan built around the whole person rather than a protocol designed to reduce prescribing liability. Why imaging technology misses the majority of pain causes at the microscopic level, and what happens when clinicians assume that what the scan cannot find must be psychological. John's take on post-surgical pain management in America: what it means when hospitals advocate for Tylenol-only pain protocols after total knee replacement, and why that trend concerns him as a practicing anesthesiologist. The patient advocacy landscape in Australia: what Chronic Pain Australia is doing on the ground with peer support groups and at the federal government level in Canberra to have chronic pain recognized and funded as a chronic disease in its own right. What Kevin would say to every prescriber, policymaker, and clinic operator if he had one sentence: treat the individual, treat the whole person, and do not assume that because you cannot find a physical cause the pain is not real. About the Hosts John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch. Connect with John: https://www.linkedin.com/in/john-hsu-md-300a8b2a/ William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit. Connect with William: https://www.linkedin.com/in/williampedranti/ About the Guest Kevin James is a chronic pain patient and patient advocate based in Brisbane, Queensland, Australia. He is a member of Chronic Pain Australia, the only organization in Australia providing face-to-face peer support groups for people living with chronic pain, and is involved in advocacy efforts at the federal government level to have chronic pain recognized and funded as a standalone chronic disease. He speaks in a personal capacity. Website: thesavingdose.com This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions. #ChronicPain #OpioidUseDisorder #PainManagement #AddictionMedicine #BehavioralHealth #TheSavingDose #HealthcarePodcast #ChronicPainAwareness #OpioidCrisis #PatientAdvocacy #PainPatient #MOUD #AddictionRecovery #SubstanceUseDisorder #PublicHealth #HolisticHealth #ChronicPainAustralia #GlobalHealth

  3. Jul 7

    What Happens to Patients After the Prescription Runs Out | The Saving Dose Ep. 05

    In the fifth episode of The Saving Dose, Dr. John Hsu and William Pedranti go inside opioid use disorder from the ground up: what it actually is, what causes it, why the people most affected by it are being failed by a system that was never designed to treat a chronic disease like a chronic disease, and why the gap between the medications that work and the patients who receive them keeps growing. The episode opens with William's recent trip to Washington D.C., where he met with members of Congress from both sides of the aisle and visited the White House to discuss the opioid crisis facing America's veterans. What he found: unanimous agreement that the crisis is real, and a treatment infrastructure that cannot come close to meeting the need. 418,000 veterans are living with opioid use disorder. Only 6,500 are currently being treated. 44 die every day from suicide and opioid overdose. This episode covers why opioid use disorder is a chronic medical condition and not a willpower problem, what the science actually says about brain chemistry versus environment, and why treating the addiction without treating the whole person produces a predictable failure rate that the system keeps misreading as patient noncompliance. In this episode: What opioid use disorder actually is clinically, why it is not the same as opioid dependency, and why the healthcare system keeps confusing the two in ways that cost lives. Why 50 to 80% of patients with OUD also carry a co-occurring psychiatric diagnosis including depression, anxiety, PTSD, or ADHD, and what happens when clinicians treat the addiction without addressing what drove the person to opioids in the first place. The Vietnam veteran study: why 80 to 90% of soldiers who were addicted to heroin stopped using when they returned to a changed environment, what that tells us about the role of circumstance in addiction, and why it does not mean addiction is just a choice. Adverse childhood experiences: why a history of four or more ACEs raises the risk of developing opioid use disorder fourfold, and why that number matters for how treatment should be designed. Why only 4 to 6% of people who misuse prescription opioids ever progress to illicit heroin or fentanyl, and what that means for the prescribing policy decisions that have left millions of chronic pain patients undertreated. The prescription cliff: what happens when a patient leaves the pharmacy and why, in John's words, remote medication adherence monitoring stops at the patient's front door. Why the medications work, why the stigma around them is wrong, and why a patient on Suboxone or methadone still has every right to receive opioids for acute or chronic pain. Why opioid use disorder has to be treated like what it is: a chronic medical condition that requires sustained management, not a thirty-day program and a handshake at discharge. William's story about a friend's brother who, after thirty years of managing addiction as a chronic disease, voluntarily checked himself back into residential treatment before relapse rather than after. About the Hosts John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch. Connect with John: https://www.linkedin.com/in/john-hsu-md-300a8b2a/ William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit. Connect with William: https://www.linkedin.com/in/williampedranti/ Kendra Allen is the CRO of iPill with 20 years in behavioral health revenue strategy, payer contracting, and regulatory navigation. She founded and exited a national healthcare consulting firm. Connect with Kendra: https://www.linkedin.com/in/kendra-allen-cro/ Website: thesavingdose.com This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions. #OpioidCrisis #AddictionRecovery #OpioidUseDisorder #MOUD #MedicationAdherence #BehavioralHealth #AddictionMedicine #VeteransMentalHealth #OpioidTreatment #SubstanceUseDisorder #HealthcarePodcast #TheSavingDose #ChronicDisease #PTSD #PublicHealth #MentalHealth #DrugPolicy #OpioidEpidemic #VeteransHealth

  4. Jun 23

    The Business of Opioid Treatment | The Saving Dose Ep. 04

    In the fourth episode of The Saving Dose, William Pedranti and Kendra Allen continue their conversation on the operational reality inside opioid treatment programs and get into the part of addiction recovery that almost nobody in the industry talks about publicly: what happens after the patient walks out the door, why most of them do not come back, and why the system was never designed to know the difference. This episode covers the economics of running an addiction treatment practice, why alcohol addiction is in many ways harder to treat than opioid addiction, how the shame and guilt cycle quietly destroys the clinical relationship, and what one text message from a counselor named Ashley revealed about how close patients can be to relapse without anyone knowing. In this episode: Why money is the single biggest barrier to addiction treatment in America, and why insurance coverage gaps mean that many people who need care most are the least able to access it. Why alcohol addiction may be harder to treat than opioid addiction, and what social acceptability has to do with it. The shame and guilt cycle: why patients who relapse between visits almost never tell their provider the truth, why that silence is a predictable system failure rather than a character flaw, and what a story about poppy seed muffins reveals about how broken the feedback loop is. What opioid treatment programs are actually up against: staffing shortages, burnout, Medicaid reimbursement pressure, patient churn, and a geography problem that puts clinics hours away from the patients who need them most. Alumni programs: what they are, why they matter, and why the story of Ashley texting a patient she had not spoken to in a year captures exactly what the gap between visits actually costs. How the addiction census grows in economic downturns, why designer drugs and animal tranquilizers are creating new crisis points in cities like Seattle, and what Kendra means when she says we are here to help the desperate. Where opioid treatment programs are headed, what the industry is trying to embrace, and why the providers who stay in this space are there for reasons that have nothing to do with the money. William's personal story: picking up a close friend's brother from a sober living facility after thirty days, and what it means when someone says recovery is sometimes day to day and sometimes minute to minute. About the Hosts John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch. Connect with John: https://www.linkedin.com/in/john-hsu-md-300a8b2a/ William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit. Connect with William: https://www.linkedin.com/in/williampedranti/ Kendra Allen is the CRO of iPill with 20 years in behavioral health revenue strategy, payer contracting, and regulatory navigation. She founded and exited a national healthcare consulting firm. Connect with Kendra: https://www.linkedin.com/in/kendra-allen-cro/ Website: thesavingdose.com Disclaimer: This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions. #OpioidCrisis #AddictionRecovery #OpioidUseDisorder #MedicationAdherence #MOUD #BehavioralHealth #AddictionMedicine #OpioidTreatment #SubstanceUseDisorder #HealthcarePodcast #TheSavingDose #RecoveryPodcast #MentalHealth #PublicHealth #PatientRetention #MAT #AlcoholAddiction #OTPChallenges #PatientChurn #AddictionTreatment

  5. Jun 9

    Inside the Black Box of Addiction Treatment | The Saving Dose Ep. 03

    In the third episode of The Saving Dose, William Pedranti sits down with Kendra Allen to map the full continuum of addiction treatment in America and go inside the operational reality of the clinics trying to deliver it. This is not a conversation about clinical failure. It is a conversation about what happens in the seven days between appointments, why most practices have no visibility into that window, and why that invisibility is where most recoveries end. This episode covers the levels of care most families do not know exist until they are desperate, what medication-assisted treatment actually is and why the stigma around it is costing lives, how opioid treatment programs are bleeding patients they cannot afford to lose, and what Kendra calls the black box: the gap between the clinic visit and the outcome where providers are flying blind and patients are on their own. In this episode: What you can do when a loved one needs addiction treatment, why calling your insurance company may not be the right first step, and how to potentially navigate a system that was not designed to be navigated by someone in crisis. The full continuum of care from detox through residential to partial hospitalization, intensive outpatient, and MAT: what each level means, what it may cost, and what could drive the decision between them. Why medication-assisted treatment may not be giving patients a synthetic high, where the stigma around MAT can come from, and what that stigma may do to the patients who need it most. The shame cycle: some reasons why patients who relapse between visits do not tell their providers the truth, what that dishonesty can cost the clinical relationship, and why it may be a predictable system failure rather than a character flaw. What it looks like inside a clinic when a patient walks in with a dirty drug test and a story about poppy seed muffins, and what a provider is supposed to do with that. Why the seven to fourteen days of medication a patient takes home can be one of the highest-risk windows in recovery, and what can happen when that medication exists in a household where someone else is also struggling. Outcomes happen between visits. What Kendra means by that, what her definition of the black box actually is, and why closing it can be the central operational and clinical challenge facing opioid treatment programs in America. Why patient churn is not a marketing problem or a clinical problem but an infrastructure problem. About the Hosts John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch. Connect with John: https://www.linkedin.com/in/john-hsu-md-300a8b2a/ William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit. Connect with William: https://www.linkedin.com/in/williampedranti/ Kendra Allen is the CRO of iPill with 20 years in behavioral health revenue strategy, payer contracting, and regulatory navigation. She founded and exited a national healthcare consulting firm. Connect with Kendra: https://www.linkedin.com/in/kendra-allen-cro/ Website: thesavingdose.com This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions. #OpioidCrisis #AddictionRecovery #OpioidUseDisorder #MedicationAdherence #MOUD #BehavioralHealth #AddictionMedicine #OpioidTreatment #SubstanceUseDisorder #HealthcarePodcast #TheSavingDose #RecoveryPodcast #MentalHealth #PublicHealth #PatientRetention #MAT #ChronicPain

  6. May 27

    Why Doctors Are Afraid to Prescribe Pain Medication | The Saving Dose Ep. 02

    In the second episode of The Saving Dose, John Hsu MD and William Pedranti go deep into the most dangerous misconceptions driving the opioid epidemic, why physicians are afraid to prescribe, what the difference between dependency and addiction actually means clinically, and why America is in its fourth decade of a crisis that has a known solution most patients never receive. This episode covers the clinical realities most pain physicians will not say publicly, the myths inside the healthcare system that are directly causing patient harm, and what it would actually take to close the gap between the treatments that exist and the patients who need them. In this episode: Why over 90% of pain physicians John knows personally are afraid to prescribe opioids, and what that fear is doing to patients in legitimate pain. The difference between opioid dependency and opioid use disorder, why the healthcare system keeps confusing the two, and why that confusion is costing lives. What happened in pain medicine clinics after the 2016 CDC guidelines, the term that emerged in physician circles, and what it tells us about the consequences of policy without infrastructure. Why a cancer patient on opioids for years is not an addict, and what happens when their medication is stopped without a proper taper. The multimodal pain therapy approach John was using in 1999 that colleagues thought was acupuncture from China, and why Medicare took 30 years to catch up. What happens when an OUD patient goes into surgery and their anesthesiologist does not know how to manage their medications, and why this scenario is more common than anyone admits. 88% of opioid overdoses today are from illicit fentanyl, not prescription medications, and what that means for how we are treating the wrong problem. 48 million Americans living with addiction, 5,000 board-certified addiction medicine physicians, and what that ratio says about why we are still in the fourth decade of this epidemic. Why the medications that reduce overdose risk by more than 50% exist, and why only 25% of the people who need them are receiving them consistently. About the Hosts John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch. Connect with John: https://www.linkedin.com/in/john-hsu-md-300a8b2a/ William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit. Connect with William: https://www.linkedin.com/in/williampedranti/ Kendra Allen is the CRO of iPill with 20 years in behavioral health revenue strategy, payer contracting, and regulatory navigation. She founded and exited a national healthcare consulting firm. Connect with Kendra: https://www.linkedin.com/in/kendra-allen-cro/ Website: thesavingdose.com Disclaimer: This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions. #OpioidCrisis #AddictionRecovery #OpioidUseDisorder #MedicationAdherence #PainManagement #MOUD #BehavioralHealth #AddictionMedicine #SubstanceUseDisorder #HealthcarePodcast #TheSavingDose #RecoveryPodcast #OpioidTreatment #ChronicPain #PublicHealth #DrugPolicy #FentanylCrisis #OpioidEpidemic

  7. May 21

    Why Addiction Treatment Is Failing America | The Saving Dose Ep. 01

    In the first episode of The Saving Dose, three addiction medicine and behavioral health executives discuss why opioid use disorder treatment is failing patients, what the medication adherence gap actually looks like from inside the clinic, and what it will take to fix it. Topics include MOUD access, buprenorphine barriers, pain management misconceptions, behavioral health revenue challenges, and the infrastructure gap driving medication non-adherence across America. This episode covers who they are, what brought them to this space, and why they believe the addiction treatment system is failing not because the science is missing, but because the infrastructure to deliver it consistently has never been built. In this episode: Why John Hsu MD walked away from a traditional anesthesiology career to build a medication security company, and the moment in his own clinic that made it impossible not to. What William Pedranti learned after 20 years building biotech companies about the gap between clinical evidence and real-world patient outcomes, and why addiction treatment has the widest gap he has ever seen. What Kendra Allen saw working on the frontlines of behavioral health, and why patients in active recovery were losing access to treatment not because they stopped trying, but because the system stopped making it possible. The parking lot: what John's patients were doing before their appointments, and what it told him about the failure of in-home medication management. The access problem in a single number: over 50% of patients can be saved by taking their medications consistently. Only 25% of them can access those medications. Why every person William tells about iPill responds the same way, and what that says about how close this crisis is to every family in America. What recovery actually requires: medication, consistency, and a system that does not make patients fight for both every single day. About the Hosts John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch. Connect with John: https://www.linkedin.com/in/john-hsu-md-300a8b2a/ William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit. Connect with William: https://www.linkedin.com/in/williampedranti/ Kendra Allen is the CRO of iPill with 20 years in behavioral health revenue strategy, payer contracting, and regulatory navigation. She founded and exited a national healthcare consulting firm. Connect with Kendra: https://www.linkedin.com/in/kendra-allen-cro/ Website: thesavingdose.com Disclaimer: This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions. #OpioidCrisis #AddictionRecovery #OpioidUseDisorder #MedicationAdherence #MOUD #BehavioralHealth #AddictionMedicine #PainManagement #SubstanceUseDisorder #HealthcarePodcast #TheSavingDose #MentalHealth #RecoveryPodcast #OpioidTreatment #PublicHealth

  • 7 Episodes

Ratings & Reviews

5
out of 5
2 Ratings

About

The podcast for those building the future of healthcare. A clinician, a healthcare attorney, and a behavioral health executive on what's actually working in addiction, adherence, and the capital reshaping both.75% of patients do not take medications as prescribed. 125,000 Americans die from it every year. $528 billion in preventable costs trace directly to a gap the healthcare system has known about for decades and never closed: what happens after the prescription is written. The Saving Dose is a podcast about that gap, the space between the clinic visit and the outcome, between the evidence-based treatment and the patient who never receives it, between the innovation that works and the reimbursement system that decides whether anyone can afford to deliver it. Hosted by Kendra Allen, Dr. John Hsu, and William Pedranti, the show brings together a behavioral health revenue strategist, an addiction medicine physician, and a biotech entrepreneur to go inside the clinical, operational, and commercial realities of addiction recovery, medication adherence, opioid use disorder (OUD), and behavioral health. Three different vantage points on the same broken system. Honest about what fails, specific about why, and direct about what a real fix requires. Topics include: MOUD and MAT clinic operations, medication-assisted treatment adherence, behavioral health reimbursement, opioid use disorder treatment, payer contracting, DEA compliance, FFS-to-value-based care transitions, and the patient adherence gap in controlled substance prescribing. The Saving Dose is for investors evaluating the addiction recovery and behavioral health infrastructure market. For clinic operators and executives running opioid treatment programs, MOUD practices, and behavioral health facilities. For clinicians in addiction medicine and pain management. For payers and administrators navigating the cost and risk of behavioral health coverage. New episodes every two weeks. Available on Spotify, Apple Podcasts, YouTube, and wherever you listen.

Information

  • Creator
    John Hsu, Kendra Allen, William Pedranti
  • Years Active
    2026
  • Episodes
    7
  • Rating
    Clean
  • Copyright
    © 2026 The Saving Dose
  • Show Website
    The Saving Dose